State Street SPDR S&P Biotech ETF (XBI) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

10.53B

Fund Score

Key Statistics

Open

$149.57

High

$155.47

52 Wk High

$165.71

AUM

10.53B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

11.57M

Market Cap

$17.32B

Mgmt Fee

0.35%

P/E Ratio

17.47

Prev. Close

$152.00

Low

$149.15

52 Wk Low

$84.39

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.87M

Beta

0.82

Avg. Expense Ratio

0.35%

P/B Ratio

4.67

Recent SPDR Series Trust - SPDR S&P Biotech ETF News

Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.

Chandrima Sanyal

Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data

Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.

Akanksha Bakshi

Taiwan Semiconductor, Freeport-McMoRan And More On CNBC's 'Final Trades'

Stephen Weiss chose Taiwan Semiconductor as final trade, citing partnership with Applied Materials. Other picks? Freeport-McMoRan.

Avi Kapoor

FAQ

How do I buy State Street SPDR S&P Biotech ETF (XBI) stock?

You can purchase shares of State Street SPDR S&P Biotech ETF (ARCA:XBI) through any online brokerage.

View our list of the best stock brokerages

Who are State Street SPDR S&P Biotech ETF (XBI) competitors?

There are no as such competitors for State Street SPDR S&P Biotech ETF.

What is the forecast, or price target, for State Street SPDR S&P Biotech ETF (XBI) stock?

There is no analysis for State Street SPDR S&P Biotech ETF to provide a consensus price target.

What is the current price for State Street SPDR S&P Biotech ETF (XBI)?

The stock price for State Street SPDR S&P Biotech ETF (ARCA: XBI) is $154.07 last updated July 17, 2026 at 7:57 PM EDT.

Does State Street SPDR S&P Biotech ETF (XBI) pay a dividend?

There are no upcoming dividends for State Street SPDR S&P Biotech ETF.

When is State Street SPDR S&P Biotech ETF (ARCA:XBI) reporting earnings?

State Street SPDR S&P Biotech ETF does not have any upcoming earnings scheduled.

Is State Street SPDR S&P Biotech ETF (XBI) going to split?

There is no upcoming split for State Street SPDR S&P Biotech ETF.

Key Statistics

Open

$149.57

High

$155.47

52 Wk High

$165.71

AUM

10.53B

Dividend

$0.58

Ex-Div Date

Jun 22, 2026

Volume

11.57M

Market Cap

$17.32B

Mgmt Fee

0.35%

P/E Ratio

17.47

Prev. Close

$152.00

Low

$149.15

52 Wk Low

$84.39

Shares Out

75.22M

Yield

0.38%

Div. Freq

Avg. Volume Daily

9.87M

Beta

0.82

Avg. Expense Ratio

0.35%

P/B Ratio

4.67

About

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Small Cap Blend
Fund Inception	Jan 31, 2006
Managers	Raymond Donofrio Karl A. Schneider
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Top ETF Holdings

Symbol	Name	Share %
PRAX	Praxis Precision Medic...	1.22%
APLS	Apellis Pharmaceutical...	1.83%
IE	Alkermes Plc	1.43%
MDGL	Madrigal Pharmaceutica...	1.39%
TGTX	Tg Therapeutics Inc	1.36%
INSM	Insmed Inc	1.34%
SRRK	Scholar Rock Holding C...	1.29%
APGE	Apogee Therapeutics In...	1.28%
SMMT	Summit Therapeutics In...	1.23%
ARWR	Arrowhead Pharmaceutic...	1.23%